PaO2/FiO2 ratio and NT-proBNP were assessed at baseline, 24 hours, 3 days, and 7 days, while mPAP was measured at baseline, 24 hours, and 7 days. Safety endpoints included mortality, hemodynamic ...
Although the PaO 2/FiO 2 derived from arterial blood gas analysis remains the gold standard for the diagnosis of acute respiratory failure, the SpO2/FiO2 has been investigated as a potential ...
Background In critically ill patients the PaO2/FIO2 ratio is an indicator of oxygenation status and is one of the diagnostic criteria for acute respiratory distress syndrome in adults (ARDS) [1 - 4].
MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.
Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is still poorly ...
Embora a PaO2/FiO2 derivada da gasometria arterial continue sendo o padrão-ouro do diagnóstico de insuficiência respiratória aguda, a SpO2/FiO2 tem sido investigada como potencial substituta. Esta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results